Curriculum vitae

  Miguel PrudĂȘncio


"Novel 4(1H)-quinolonimine derivatives as antimalarial agents". National Application No. 20111000058481, filed 26.07.2011

"Use of inhibitors of host kinases for the treatment of infectious diseases", US provisional application NO. 61/110,217, filed 31.10.2008

"Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases" (WO/2007/101710), International Application No. PCT/EP2007/002110, National phases initialized in EU, US, CA and China in Oct. 2008

"Genetically modified rodent Plasmodium parasites as platforms for a whole-organism malaria vaccine" (WO 2013156949 A1, also published as CN104302313A, EP2838554A1, US20150071966)
Provisional application (Portugal) No. 20121000030819, filed 17.04.2012
PCT international application PCT/IB2013/053050, submitted 17.04.2013, published 24.10.2013.
Patent applications filed in Angola, Australia, Brazil, China, India, Japan, Mozambique, South Africa, United States, and European Patent (Euro-PCT), November 2014
Patent granted in India (07.08.2015), Mozambique (17.08.2015), South Africa (23.12.2015), Japan (2015), Australia (03.02.2017), USA (15.02.2017) and China (20.11.2017).

"Infected Cell Cultures", European Patent Office application EP 17 160 277.4, filed on 10.03.2017. PCT application number PCT/EP2018/055717 (8 March 2018).